Stay updated on LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial

Sign up to get notified when there's something new on the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new revision label (v3.5.4) replaces the previous v3.5.3, indicating a backend or display update without changing the study information presented on the page.
    Difference
    0.1%
    Check dated 2026-05-15T23:49:33.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page’s footer revision label was updated from v3.5.2 to v3.5.3, reflecting a platform/version update without changing the underlying study details.
    Difference
    0.1%
    Check dated 2026-04-24T16:51:32.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:39:21.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T20:46:57.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.3; the previous label v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T17:23:58.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Administrative updates include revision v3.4.2 and removal of revisions v3.4.1 and a government funding lapse notice; to avoid alerts for small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:42:00.000Z thumbnail image

Stay in the know with updates to LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page.